Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Astrana Health (ASTH)

Astrana Health Q2 revenue up 49% to $972.5 million; raises 2026 adjusted EBITDA guidance

Positive Impact 4 of 5 earnings Written later

Astrana Health reported second-quarter 2026 revenue of $972.5 million, up 49% from a year earlier, and net income attributable to Astrana of $19.7 million, up 109%. The company raised its full-year 2026 adjusted EBITDA guidance to $255 million to $280 million and reaffirmed its revenue and free cash flow guidance, which points to stronger profitability for shareholders.

Key points

  • Q2 2026 diluted EPS was $0.40, up 111% from $0.19; adjusted EBITDA was $68.9 million, up 43%
  • Full-year 2026 adjusted EBITDA guidance is $255 million to $280 million; full-year revenue guidance of $3.8 billion to $4.1 billion was reaffirmed
  • Q3 2026 revenue guidance is $1.00 billion to $1.03 billion; Q3 adjusted EBITDA guidance is $72.5 million to $77.5 million
  • Care Partners income from operations fell 14% in Q2, and the Care Delivery segment posted an operating loss of $3.0 million

The filing

CompanyAstrana Health (ASTH)
Form8-K, current report
Filed with the SECAug 6, 2026, 4:11 PM ET
Accession number0001104659-26-092003

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:54 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 06, 2026.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.